---
title: "BERNS PAUL L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/32e44a5a-fb20-573d-88e5-3cbd8a2485fb
json: https://whiteintel.dev/api/public/dossier/32e44a5a-fb20-573d-88e5-3cbd8a2485fb
identifier: sec:0001202769
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# BERNS PAUL L

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001202769`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/32e44a5a-fb20-573d-88e5-3cbd8a2485fb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/32e44a5a-fb20-573d-88e5-3cbd8a2485fb  

## Ownership & control

### Holdings / subsidiaries

- **Neumora Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1215113d-0999-5daf-9908-343ef157702c
- **Neumora Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1215113d-0999-5daf-9908-343ef157702c
- **Metsera, Inc.** (director) — https://whiteintel.dev/entity/545e3c76-456f-5273-ab91-538a1a34ba68
- **Metsera, Inc.** (10% owner) — https://whiteintel.dev/entity/545e3c76-456f-5273-ab91-538a1a34ba68
- **ALLOS THERAPEUTICS** (officer) — https://whiteintel.dev/entity/4e00b74d-beb6-5d0f-ba45-4ae0f366fc77
- **KARDIGAN, INC.** (director) — https://whiteintel.dev/entity/713e6c89-10c4-5a70-9f1d-70e829db1a7c
- **KARDIGAN, INC.** (tenpercentowner) — https://whiteintel.dev/entity/713e6c89-10c4-5a70-9f1d-70e829db1a7c
- **Neumora Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1215113d-0999-5daf-9908-343ef157702c
- **Neumora Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/1215113d-0999-5daf-9908-343ef157702c
- **Lyell Immunopharma, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/eeb1283f-805a-5e39-98c5-0756afaf7715
- **Metsera, Inc.** (director) — https://whiteintel.dev/entity/545e3c76-456f-5273-ab91-538a1a34ba68
- **Metsera, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/545e3c76-456f-5273-ab91-538a1a34ba68
- **Unity Biotechnology, Inc.** (director) — https://whiteintel.dev/entity/38e751f5-84a0-5904-a275-8e05eeba65b5
- **CM LIFE SCIENCES III INC.** (director) — https://whiteintel.dev/entity/f9a124ec-470b-5586-9490-67830f9b5a67
- **Jazz Pharmaceuticals plc** (director) — https://whiteintel.dev/entity/93c43bdd-29a5-5302-94c3-e122c135c53f
- **VYNE Therapeutics Inc.** (director) — https://whiteintel.dev/entity/d382a860-279d-5548-a93d-0f56d28acd45
- **ANACOR PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/2f26174c-e32a-570d-a3de-de82f180e980
- **ANACOR PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/2f26174c-e32a-570d-a3de-de82f180e980
- **XENOPORT INC** (director) — https://whiteintel.dev/entity/0e80dd14-a73f-5502-a7ba-4a74b62493a4
- **Cellectar Biosciences, Inc.** (director) — https://whiteintel.dev/entity/a4043273-e91c-5473-8d42-7a747b3061b6

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BERNS PAUL L**. Human view: https://whiteintel.dev/entity/32e44a5a-fb20-573d-88e5-3cbd8a2485fb · Structured JSON: https://whiteintel.dev/api/public/dossier/32e44a5a-fb20-573d-88e5-3cbd8a2485fb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._